Meetings:

Federal Register: March 21, 2011 (Volume 76, Number 54)

Notices

Page 15329

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr21mr11-69

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5

USC, as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute on Drug Abuse Special

Emphasis Panel, R25 Summer Programs.

Date: March 30, 2011.

Time: 11 a.m. to 1 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Neuroscience Center, 6001

Executive Boulevard, Rockville, MD 20852 (Telephone Conference

Call).

Contact Person: Gerald L. McLaughlin, PhD, Scientific Review

Officer, Office of Extramural Affairs, National Institute on Drug

Abuse, NIH, DHHS, Room 4238, MSC 9550, 6001 Executive Blvd.,

Bethesda, MD 20892-9550, 301-402-6626, gm145a@nih.gov.

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug

Abuse and Addiction Research Programs, National Institutes of

Health, HHS)

Dated: March 15, 2011.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

FR Doc. 2011-6578 Filed 3-18-11; 8:45 am

BILLING CODE 4140-01-P

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT